We serve Chemical Name:3,7,7-trimethyl-5-(3-methylbut-2-enyl)bicyclo[4.1.0]heptan-4-one CAS:74499-58-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![3,7,7-trimethyl-5-(3-methylbut-2-enyl)bicyclo[4.1.0]heptan-4-one](https://a.dearchem.com/CAS2/74499-58-4.png)
Chemical Name:3,7,7-trimethyl-5-(3-methylbut-2-enyl)bicyclo[4.1.0]heptan-4-one
CAS.NO:74499-58-4
Synonyms:einecs 277-895-1
Molecular Formula:C15H24O
Molecular Weight:220.35000
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:286.6ºC at 760 mmHg
Density:0.915g/cm3
Index of Refraction:1.473
PSA:17.07000
Exact Mass:220.18300
LogP:3.84000
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like einecs 277-895-1 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,einecs 277-895-1 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,einecs 277-895-1 Use and application,einecs 277-895-1 technical grade,usp/ep/jp grade.
Related News: Government prosecutors often consider whether a corporation made a genuine effort to investigate and address potentially illegal activities once learning of them. 3,7,7-trimethyl-5-(3-methylbut-2-enyl)bicyclo[4.1.0]heptan-4-one manufacturer Government prosecutors often consider whether a corporation made a genuine effort to investigate and address potentially illegal activities once learning of them. 3,7,7-trimethyl-5-(3-methylbut-2-enyl)bicyclo[4.1.0]heptan-4-one supplier Active pharmaceutical ingredients affect the structure and function of the human body. Inactive ingredients in a pharmaceutical may be referred to as bulk pharmaceutical chemicals (BPCs). 3,7,7-trimethyl-5-(3-methylbut-2-enyl)bicyclo[4.1.0]heptan-4-one vendor FT819 is derived from a clonal master engineered induced pluripotent stem cell (iPSC) line with complete elimination of T-cell receptor (TCR) expression and a novel 1XX CAR targeting CD19 inserted into the T-cell receptor alpha constant (TRAC) locus. 3,7,7-trimethyl-5-(3-methylbut-2-enyl)bicyclo[4.1.0]heptan-4-one factory FT819 is derived from a clonal master engineered induced pluripotent stem cell (iPSC) line with complete elimination of T-cell receptor (TCR) expression and a novel 1XX CAR targeting CD19 inserted into the T-cell receptor alpha constant (TRAC) locus.
